Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Other Non-Current Assets (2021 - 2025)

Senti Biosciences has reported Other Non-Current Assets over the past 5 years, most recently at $19000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 81.9% year-over-year to $19000.0; the TTM value through Dec 2025 reached $19000.0, down 81.9%, while the annual FY2025 figure was $19000.0, 81.9% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $19000.0 at Senti Biosciences, down from $34000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $6.4 million in Q3 2023 and troughed at $19000.0 in Q4 2025.
  • A 5-year average of $2.0 million and a median of $1.5 million in 2021 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: surged 1585.17% in 2023 and later crashed 99.05% in 2025.
  • Year by year, Other Non-Current Assets stood at $3.3 million in 2021, then tumbled by 93.58% to $209000.0 in 2022, then surged by 1585.17% to $3.5 million in 2023, then tumbled by 97.02% to $105000.0 in 2024, then crashed by 81.9% to $19000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for SNTI at $19000.0 in Q4 2025, $34000.0 in Q3 2025, and $52000.0 in Q2 2025.